THIS SEARCH     THIS DOCUMENT     GO TO
Next Hit        Forward           New Bills Search
Prev Hit        Back              HomePage
Hit List        Best Sections     Help
                Contents Display   

Bill PDFBillno should always have and extension i.e. h1.ih

Printer Friendly[Help]

Congressional Record References

Bill Summary & Status

HR 2966 IH

To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs.

June 19, 2009

Mr. NADLER of New York introduced the following bill; which was referred to the Committee on Ways and Means

To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the `Say No to Drug Ads Act'.

SEC. 2. DISALLOWANCE OF DEDUCTION FOR DIRECT-TO-CONSUMER ADVERTISEMENT OF PRESCRIPTION DRUGS.

(a) General Rule- Part IX of subchapter B of chapter 1 of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section:

`SEC. 280I. DIRECT-TO-CONSUMER ADVERTISEMENT OF PRESCRIPTION DRUGS.

`No deduction shall be allowed under this chapter for any amount paid or incurred for a direct-to-consumer advertisement of a prescription drug.'

(b) Clerical Amendment- The table of sections for part IX of subchapter B of chapter 1 of such Code is amended by adding at the end thereof the following new item:

`Sec. 280I. Direct-to-consumer advertisement of prescription drugs.'.

(c) Effective Date- The amendments made by this section shall apply to amounts paid or incurred after December 31, 2009.